Mission

Redefining healthcare through a paradigm shift from treatment to prevention. 

Theragen Health delivers advanced genetic analysis services for healthcare. 

Vision

Theragen Health for better healthcare services 

Healthcare for all 

We envision a world where high quality healthcare is accessible to all 

Through the story written in your DNA,
we continuously innovate to help you achieve a healthier tomorrow.

10+ years of proven service in Asia 

Backed by trusted expertise and a network
of over 800 medical institutions
across Korea

Comprehensive DTC genetic testing across cancer, common, pharmacogenomic,
and rare diseases, delivering unbiased, genetics-driven insights. 

Built on a customer-centric mindset 

Closer. More accurate. Simpler 

We are committed to making genetic testing more accessible, and results easier to understand clearly and precisely. 

Healthcare for all 

We envision a world where high quality healthcare

is accessible to all 

Through the story written in your DNA,

we continuously innovate to help you achieve a healthier tomorrow.

10+ years of proven service in Asia

Backed by trusted expertise and a network

of over 800 medical institutions across Korea 

Offering one of the most comprehensive DTC genetic testing portfolios

spanning cancer, common diseases, pharmacogenomics, and rare diseases,

we deliver unbiased, genetics driven insights and services.

Built on a customer-centric mindset

Closer. More accurate. Simpler 

We are committed to making genetic testing more accessible,

and results easier to understand clearly and precisely. 

THERAGEN Group

Theragen Health spans the entire bio industry 

Theragen
Health

Healthcare Genetic Analysis Service Established in 2022

Theragen Health is a joint venture between

Daeil Pharmaceutical and Theragen Bio,
and a global leader in the personal genomics market. 

Integrated Pharmaceutical and Bio Group

mobile background

Achievements

Research Achievements 

Theragen Health possesses both advanced

genomic analysis technologies and service capabilities,
key to the era of precision medicine. 

[Major Government-Funded Projects ]

  • [Lead Institution] Mar 2018 – Jun 2019. Research Project, Korea Disease Control and Prevention Agency (KDCA)
    Systematic analysis of genetic variations in alcohol-metabolizing enzymes and their association with diseases in Korea  [Project No. 2018ER640300]
  • [Participating Institution] Oct 2018 – Dec 2020. National Innovation Cluster Project, Ministry of Trade, Industry and Energy (MOTIE)
    Development of personalized cosmetics technologies based on big data [Project No. P0006712]
  • [Participating Institution] Oct 2020 – Dec 2022. National Innovation Cluster Project (Performance Completion), MOTIE
    Development of a personalized cosmetics service platform for skin health [Project No. P0015296]
  • [Lead Institution] Sep 2018 – May 2022. Bio Industry Core Technology Development Program, MOTIE
    Development of a user-participatory big data-based health risk prediction and management service [Project No. 20002781]
  • [Lead Institution] Mar 2020 – Dec 2021. Regulatory Sandbox Project, MOTIE [Industrial Convergence Promotion Act]
  • [Sub-project] Oct 2018 – Dec 2022. National Research Foundation of Korea (NRF)
    Development of integrated cognitive technologies for identification of missing persons [Project No. 2018M3E3A1057354]
  • [Consortium Member] Apr 2021 – Dec 2025. Future Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA)
    Development of personalized dietary management solutions and home meal replacements based on demand [Project No. 321030-5]

[ Publications ]

  1. Identification of serotonin receptor gene variants associated with type 2 diabetes (Diabetes Research and Clinical Practice, 2019)
  2. Validation of genetic variants associated with diabetes risk in kidney transplant patients (Journal of Clinical Medicine, 2019)
  3. Association between salt intake and hypertension risk based on genetic variation (Nutrients, 2020)
  4. Genetic variants associated with skin aging in Koreans (Journal of Cosmetic Science, 2021)
  5. Genetic markers increasing cardiovascular disease risk in patients with hypertension, diabetes, and hyperlipidemia (Journal of Translational Medicine, 2021)
  6. Genetic indicators influencing obesity and metabolic diseases (Scientific Reports, 2021)
  7. Genetic markers affecting liver disease risk based on alcohol consumption (Hepatology, 2022)
  8. Genetic markers influencing metabolic disease risk by obesity status (Scientific Reports, 2021)
  9. Gene–nutrient interactions increasing obesity risk (Clinical Nutrition, 2022)
  10. Genetic variants associated with hypertension based on renin levels (Journal of Cardiovascular Development and Disease, 2022)
  11. Genome-wide study of male pattern baldness (Journal of Cosmetic Dermatology, 2022)
  12. Association of postmenopausal obesity in breast cancer patients with genetic factors and Mediterranean diet(Frontiers in Nutrition, 2022)
  13. Genetic markers influencing cardiovascular risk in hyperlipidemia patients (Biomedicines, 2022)
  14. Genetic indicators affecting metabolic disease risk by sex and life stage (International Journal of Molecular Sciences, 2022)
  15. Novel genetic markers related to skin aging in Koreans (Applied Sciences, 2022)
  16. Interaction between PNPLA3 genotype and nutrient intake in NAFLD (Nutrients, 2022)
  17. Interaction study on BMI and body fat percentage in Koreans (Disease Markers, 2023)
  18. Genetic factors associated with left-handedness (Brain and Behavior, 2023)
  19. Genetic variants associated with weight loss and dietary changes due to digital lifestyle (Scientific Reports, 2023)
  20. Reliability and validity of sleep quality index using wearable devices (Korean Journal of Family Medicine, 2023)
  21. Genetic variants associated with cardiovascular risk in fatty liver patients (Nutrients, 2024)
  22. Relationship between water intake and diet based on genetic types (PLOS ONE, 2024)
  23. Genetic factors related to COVID-19 vaccine antibody response (Moderna-funded study) (Vaccines, 2024)
  24. Study on DTC application model in pharmacies (Korean Journal of Community Pharmacy, 2024)
  25. Mediterranean diet and reduction of fatty liver risk based on genetic types (Journal of Translational Medicine, 2024)


[Patents]

  1. 10-2019-0085202 Method for predicting the risk of hair loss
  2. 10-2020-0032281 Personalized healthcare system
  3. 10-2020-0130605 Method and system for providing personalized cosmetics
  4. 10-2020-0186789 Method and apparatus for future face prediction
  5. 10-2020-0103338 Method and kit for providing information on hypertension
  6. 10-2021-0070111 Survey-based personalized skin type prediction system and method

Bio IT Solutions

Healthcare LIMS

Healthcare LIMS is a laboratory information management system designed

and developed to flexibly respond to the rapidly evolving personal genomics market. 

Features 

Delivering optimal turnaround time through optimized and automated processes

Providing flexible scalability aligned with the evolving data ecosystem

Ensuring reliable and secure genetic and personal data with a proprietary RDBMS architecture.  

Supporting multiple output formats
(API, printed reports, PDF files)

Scalability

Data Flow

Pursuing differentiated services by integrating genetics with healthcare lifestyle solutions
Pursuing differentiated services by integrating genetics with healthcare lifestyle solutions 

Company Name: Theragen Health Co., Ltd.   

Co-CEOs: Tae Soon Hwang, Tae Gon Lim 

Business Registration Number: 846-86-02989
E-commerce Registration Number: 2023-Seongnam Bundang-A-0917
Data Protection Officer: Seok Won Jung 

Address: Room 1003, 10F, A-dong, Samhwan Hipex, 240 Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
Tel: +82-1522-2375         Fax: +82-31-288-1294 

Privacy Policy       Terms of Use ㅤ COPYRIGHT (C) Theragen Health All Rights Reserved. 

Company Name: Theragen Health Co., Ltd.        Co-CEOs: Tae Soon Hwang, Tae Gon Lim        Business Registration Number: 846-86-02989 
E-commerce Registration Number: 2023-Seongnam Bundang-A-0917        Data Protection Officer: Seok Won Jung
Address: 15F, Giheung ICT Valley Bldg. B, 58, Giheung-ro, Giheung-gu, Yongin-si, Gyeonggi-do, Republic of Korea 

Tel: +82-1522-2375         Fax: +82-31-284-0253 

Privacy Policy       Terms of Use ㅤㅤ COPYRIGHT (C) Theragen Health All Rights Reserved.